Promising treatment outcomes of intensity-modulated radiation therapy for nasopharyngeal carcinoma patients with N0 disease according to the seventh edition of the AJCC staging system
Open Access
- 15 February 2012
- journal article
- Published by Springer Science and Business Media LLC in BMC Cancer
- Vol. 12 (1), 68
- https://doi.org/10.1186/1471-2407-12-68
Abstract
Intensity-modulated radiation therapy (IMRT) provides excellent locoregional control for nasopharyngeal carcinoma (NPC), and has gradually replaced two-dimensional conventional radiotherapy as the first-line radiotherapy technique. Furthermore, in the new seventh edition of the American Joint Committee on Cancer (AJCC) staging system, retropharyngeal lymph nodes were upgraded from N0 to N1 disease as a result of their negative impact on the distant metastasis-free survival (DMFS) rates of NPC. This retrospective study was conducted in order to review the treatment outcomes and patterns of failure in NPC patients with N0 disease after IMRT in order to effectively guide treatment in the future. We retrospectively reviewed data from 506 biopsy-proven nonmetastatic NPC patients. There were 191 patients with negative cervical lymph node involvement. According to the seventh edition of the American Joint Committee on Cancer (AJCC) staging system, 110 patients (21.7%) were staged with N0 disease, and 81 patients (16.0%) were reclassified with N1 disease due to the presence of RLN metastasis. All patients received IMRT as the primary treatment. In patients with negative cervical lymph node involvement, distant metastasis-free survival (DMFS) was significantly higher in patients without retropharyngeal lymph node (RLN) metastasis than those with RLN metastasis (95.9% vs. 88.1% respectively, P = 0.04). For N0 disease, the 5-year overall survival (OS), local relapse-free survival (LRFS), nodal relapse-free survival (NRFS) and DMFS rates were 93.8%, 97.1%, 99.1% and 95.9%, respectively. For T1N0, T2N0, T3N0 and T4N0, OS was 97.8%, 100%, 93.8% and 76.9%, LRFS was 100%, 92.9%, 100% and 88.9% and DMFS was 96.6%, 90.9%, 100% and 93.3%, respectively. OS and LRFS were higher in T1-3 N0 patients than T4N0 patients (P < 0.01 and P = 0.01, respectively). The seventh edition of the AJCC N-staging system improves prognostic accuracy by upgrading RLN metastasis to N1 disease. IMRT produces excellent survival rates in T1-3 N0 disease; however, T4N0 disease remains a challenge and additional improvements are required to achieve a favorable prognosis for these NPC patients.Keywords
This publication has 22 references indexed in Scilit:
- How Does Intensity-Modulated Radiotherapy Versus Conventional Two-Dimensional Radiotherapy Influence the Treatment Results in Nasopharyngeal Carcinoma Patients?International Journal of Radiation Oncology*Biology*Physics, 2011
- Radiation Associated Brainstem InjuryInternational Journal of Radiation Oncology*Biology*Physics, 2010
- Treatment of Nasopharyngeal Carcinoma Using Intensity-Modulated Radiotherapy—The National Cancer Centre Singapore ExperienceInternational Journal of Radiation Oncology*Biology*Physics, 2009
- Accuracy and Precision of an IGRT SolutionMedical Dosimetry, 2009
- Late complications of radiotherapy for nasopharyngeal carcinomaAuris Nasus Larynx, 2009
- Retropharyngeal nodal metastasis related to higher rate of distant metastasis in patients with N0 and N1 nasopharyngeal cancerHead & Neck, 2009
- The volume to be irradiated during selective neck irradiation in nasopharyngeal carcinomaCancer, 2009
- Retropharyngeal lymph node metastasis in nasopharyngeal carcinoma detected by magnetic resonance imagingCancer, 2008
- Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: Update of the Memorial Sloan-Kettering experienceInternational Journal of Radiation Oncology*Biology*Physics, 2006
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958